Citizens Maintains Market Outperform on TELA Bio, Lowers Price Target to $5

Benzinga · 11/14/2025 15:29
Citizens analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target from $7 to $5.